Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2015 · 10-Q
Revenue$4.27B$4.27B−1.2% vs Q2 2014 Net income—
EPS Diluted$1.27$1.27+84.1% vs Q2 2014 Gross Profit$1,941,800,000+5.2% Operating Income$595,800,000+71.2% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$764,900,000−13.9% Free Cash Flowderived$669,600,000−17.7% Margins · derivedGross margin45.5%+2.7 pt vs Q2 2014
Operating margin14.0%+5.9 pt vs Q2 2014
ended Jun 27, 2015 · filed Jul 31, 2015 · 34 d after period end